Abstract:Here we uncover a pathological mechanism in Alzheimer's disease linking abnormal hypermetabolism of glucose in hiPSC‐derived astrocytes and neurons to an abnormal and potentially toxic glutamate accumulation. Increased glucose metabolism was found in astrocytes and neurons carrying familial Alzheimer's disease mutations. Diseased astrocytes exhibit reduced expression of the excitatory amino acid transporter 2 but increased glutamate oxidative metabolism, which supports an increased synthesis of glutamine. Glutamine uptake is increased in diseased neurons, and glutamate release is enhanced completing a potentially toxic cycle. Our findings further identify metabolic and neurotransmitter imbalances that may operate at early phases of Alzheimer's disease pathophysiology. Glutamate recycling between neurons and astrocytes is essential to maintain neurotransmitter homeostasis. Disturbances in glutamate homeostasis, resulting in excitotoxicity and neuronal death, have been described as a potential mechanism in Alzheimer's disease (AD) pathophysiology. However, glutamate neurotransmitter metabolism in different human brain cells, particularly astrocytes, has been poorly investigated at the early stages of AD. We sought to investigate glucose and glutamate metabolism in AD by employing human induced pluripotent stem cell (hiPSC)‐derived astrocytes and neurons carrying mutations in the amyloid precursor protein (APP) or presenilin‐1 (PSEN‐1) gene as found in familial types of AD (fAD). Methods such as live‐cell bioenergetics and metabolic mapping using [13C]‐enriched substrates were used to examine metabolism in the early stages of AD. Our results revealed greater glycolysis and glucose oxidative metabolism in astrocytes and neurons with APP or PSEN‐1 mutations, accompanied by an elevated glutamate synthesis compared to control WT cells. Astrocytes with APP or PSEN‐1 mutations exhibited reduced expression of the excitatory amino acid transporter 2 (EAAT2), and glutamine uptake increased in mutated neurons, with enhanced glutamate release specifically in neurons with a PSEN‐1 mutation. These results demonstrate a hypermetabolic phenotype in astrocytes with fAD mutations possibly linked to toxic glutamate accumulation. Our findings further identify metabolic imbalances that may occur in the early phases of AD pathophysiology.

Characterization of Energy and Neurotransmitter Metabolism in Cortical Glutamatergic Neurons Derived from Human Induced Pluripotent Stem Cells: A Novel Approach to Study Metabolism in Human Neurons

Characteristic Metabolic Alterations Identified in Primary Neurons under High Glucose Exposure

Mass Spectrometry-Based Quantitation Combined with Time-Dependent Metabolomics to Discover Metabolic Features in Human Neurogenesis Using Neural Constructs Generated from Neural Progenitor Cells.

Metabolic Profile Variations along the Differentiation of Human-Induced Pluripotent Stem Cells to Dopaminergic Neurons

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Genomics Analysis of Metabolic Pathways of Human Stem Cell-Derived Microglia-Like Cells and the Integrated Cortical Spheroids

Functional Metabolic Mapping Reveals Highly Active Branched-Chain Amino Acid Metabolism in Human Astrocytes, Which Is Impaired in iPSC-Derived Astrocytes in Alzheimer's Disease

Directly Reprogrammed Human Neurons to Understand Age-Related Energy Metabolism Impairment and Mitochondrial Dysfunction in Healthy Aging and Neurodegeneration

Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer's disease.

A Single-Cell Model for Synaptic Transmission and Plasticity in Human iPSC-Derived Neurons

Pluripotent stem cell energy metabolism: an update

Metabolic Rewiring and Altered Glial Differentiation in an iPSC-Derived Astrocyte Model Derived from a Nonketotic Hyperglycinemia Patient

Electrophysiological- and Neuropharmacological-Based Benchmarking of Human Induced Pluripotent Stem Cell-Derived and Primary Rodent Neurons

Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC‐derived models of Alzheimer's disease

Multielectrode array characterization of human induced pluripotent stem cell derived neurons in co-culture with primary human astrocytes

Induced pluripotent stem cell-derived cells model brain microvascular endothelial cell glucose metabolism

Sustained synchronized neuronal network activity in a human astrocyte co-culture system

Preservation of an Aging-Associated Mitochondrial Signature in Advanced Human Neuronal Models

Metabolic Heterogeneity of Cerebral Cortical and Cerebellar Astrocytes

Scalable Hypothalamic Arcuate Neuron Differentiation from Human Pluripotent Stem Cells Suitable for Modeling Metabolic and Reproductive Disorders

Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience